Join us on Thursday, April 29th at 3:00 PM (ET), as the world comes to terms with the health, economic and social impacts of COVID 19, the biotechnology industry features as one of the most vital elements for Canada’s recovery. Canada has an opportunity to build from a position of strength in determining the next generation of solutions for healthcare and pandemic emergencies. With a vibrant, regionally strong life science ecosystem across Canada, drawing from both public and private networks, the potential for life sciences to drive long term sustained economic growth is unprecedented. These networks of research and academic institutions, startup companies, skilled expertise and private investments have established a globally recognized level of scientific and research excellence.

Host: Andrew Casey, President and CEO, BIOTECanada

Moderator : André Picard, The Globe & Mail

Panelists 

Philip Tagari, Head, Research and Development Amgen, Global

Molly Shoichet, Shoichet Lab, University of Toronto and Amacathera CEO

Cynthia Lavoie, President & Chief Investment Officer, CCRM Enterprises Ltd